Home › Ovarian Cancer › Texas › Killeen
Ovarian Cancer clinical trials in Killeen, TX
4 studies for Ovarian Cancer are looking for participants at sites in and around Killeen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Scott and White Memorial Hospital, Temple · 23 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Texas Oncology Gulf Coast, Woodland · 14 mi away
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Baylor Scott & White Medical Center, Temple · 23 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Temple · 23 mi away
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Killeen
- Post-Traumatic Stress Disorder8 studies
- Heart Failure6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Colon Cancer5 studies
- Bladder Cancer5 studies
- Breast Cancer4 studies
- Metastatic Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Endometrial Cancer4 studies
- Type 2 Diabetes4 studies
- Burkitt Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.